Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Q3 2023 Results Conference Call November 2, 2023 4:30 PM ET Company Participants Sharon Klahre - Head of Investor Relations Michael Metzger - Chief Executive Officer Neil Gallagher - President and Head of R&D Keith Goldan - Chief Financial Officer Peter Ordentlich - Chief Scientific Officer Anjali Ganguli - Chief Business Officer Conference Call Participants Brad Canino - Stifel Phil Nadeau - TD Cowen Peter Lawson - Barclays Michael Schmidt - Guggenheim Kalpit Patel ...